Blood pressure and hypertension for Australian Aboriginal and Torres Strait Islander people

European Journal of Preventive Cardiology

Volumn 13, Issue 3, 2006, Pages 438-443

  Wang, Zaimin ^a   Knight, Sabina ^b   Wilson, Andrew ^a   Rowley, Kevin G ^a   Best, James D ^a   Mcdermott, Robyn ^c   Leonard, Dympna ^d   Shaw, Jonathan E ^e   O'dea, Kerin ^f,g  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^d TROPICAL PUBLIC HEALTH UNIT   (Australia)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^f MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^g CHARLES DARWIN UNIVERSITY   (Australia)

Author keywords

Aboriginal people; blood pressure; body mass index; cardiovascular disease; diabetes; hypertension; indigenous health; Torres Strait Islander people

Indexed keywords

ALBUMIN; GLUCOSE;

ABORIGINE; ADOLESCENT; ADULT; AGED; AUSTRALIA; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PULSE PRESSURE; REVIEW; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TIME SERIES ANALYSIS;

ADOLESCENT; ADULT; ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; AUSTRALIA; BLOOD GLUCOSE; BLOOD PRESSURE; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; OCEANIC ANCESTRY GROUP;

EID: 33748263405     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000192744.88854.32     Document Type: Article

References (24)

1. Kannel WB. Blood pressure as a cardiovascular risk factor. Prevention andtreatment. JAMA 1996; 275: 1571–1576.
2. Whelton PK. Epidemiology of hypertension. Lancet 1994; 344: 101–106.
3. Blood Pressure Lowering Treatment Trialists' Collaboration. Effect of ACE inhibitors, calcium antagonists, and otherblood-pressure-lowering drugs. Lancet 2000; 356: 1955–1964.
4. Dunstan D, Zimmet P, Welborn T, Sicree R, Armstong T, Atkins R, et al. Diabesity and associated disorders in Australia 2000,the accelerating epidemic: the Australian diabetes, obesity and lifestylestudy (AusDiab). Melbourne: The International Diabetes Institute; 2001.
5. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control ofhypertension in the United States, 1988–2000. JAMA 2003; 290: 199–206.
6. Australian Bureau of Statistics. The health and welfare of Australia's Aboriginal and TorresStrait Islander peoples. Canberra: Australian Government Publishing Service; 1997.
7. Rowley KG, Iser DM, Best JD, O'Dea K, Leonard D, McDermott R. Albuminuria in Australian Aboriginal people: prevalence andassociations with components of the metabolic syndrome. Diabetologia 2000; 43: 1397–1403.
8. Leonard D, McDermott R, O'Dea K, Rowley KG, Pensio P, Twist A, et al. Obesity, diabetes and associated cardiovascularrisk factors among Torres Strait Islander people. Aust NZ J Public Health 2002; 26: 144–149.
9. World Health Organization. Definition, diagnosis and classification of diabetes mellituscomplications. Geneva: WHO; 1999.
10. Bennett PH, Haffner S, Kasiske BL. Screening and management of microalbuminuria in patients withdiabetes mellitus: recommendations to the Scientific Advisory Board of theNational Kidney Foundation from an ad hoc Committee of the Council onDiabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 1995; 25: 107–112.
11. European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension: European Society ofCardiology guidelines for management of arterialhypertension. J Hypertens 2003; 21: 1011–1053.
12. Abbie AA. Studies in physical anthropology. Canberra: Australian Institute ofAboriginal Studies; 1975.
13. O'Dea K. Cardiovascular disease risk factors in AustralianAborigines. Clin Exp Pharmacol Physiol 1991; 18: 85–88.
14. Smith RM, Spargo RM, King RA, Hunter EM, Correll RL, Nestel PJ. Risk factors for hypertension in KimberleyAborigines. Med J Aust 1992; 156: 562–566.
15. Wang Z, Hoy WE. Hypertension, dyslipidemia, body mass index, diabetes and smokingstatus in Aboriginal Australians in a remote community. Ethn Dis 2003; 13: 324–330.
16. Thompson PL, Bradshaw PJ, Veroni M, Wilkes ET. Cardiovascular risk among urban Aboriginalpeople. Med J Aust 2003; 179: 143–146.
17. Smith RM, Spargo RM, Hunter EM, King RA, Correll RL, Craig IH, et al. Prevalence of hypertension in KimberleyAborigines and its relationship to ischaemic heart disease. Med J Aust 1992; 156: 557–562.
18. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heartdisease?. The Framingham Heart Study. Circulation 1999; 100: 354–364.
19. Risk Factor Prevalence Study Management Committee. Risk factor prevalence study survey no 3 1989. Canberra: National HeartFoundation of Australia and Australian Institute of Health; 1990.
20. Franklin SS, Gustin W, Wong ND, Larson Mg, Weber MA, Kannel MB, et al. Hemodynamic patterns of age-related changes inblood pressure. The Framingham Heart Study. Circulation 1997; 96: 308–315.
21. Mitchell GF, Lacourciere Y, Ouellet J-P, Izzo J, Neutel J, Kerwin LJ, et al. Determinants of elevated pulse pressure inmiddle-aged and older subjects with uncomplicated systolic hypertension: Therole of proximal aortic diameter and the aortic pressure-flowrelationship. Circulation 2003; 108: 1592–1598.
22. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R, et al. Arterial stiffness, wave reflections, and therisk of coronary artery disease. Circulation 2004; 109: 184–189.
23. Hoy WE, Wang Z, Baker PR, Kelly AM. Reduction in natural death and renal failure from a systematicscreening and treatment program in an Australian Aboriginalcommunity. Kidney Int 2003; 83: S66–S73.
24. McDermott R, Tulip F, Schmidt B. Diabetes care in remote northern Australian Indigenouscommunities. Med J Aust 2004; 180: 512–516.